Harugeri A, Joseph J, Parthasarathi G, Ramesh M, Guido S. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India. Am J Geriatr Pharmacother. 2010;8(3):271-280. https://doi.org/10.1016/j.amjopharm.2010.06.004

Jetha S. Polypharmacy, the Elderly, and Deprescribing. Consult Pharm. 2015;30(9):527-532. https://doi.org/10.4140/tcp.n.2015.527

Corsonello A, Pranno L, Garasto S, Fabietti P, Bustacchini S, Lattanzio F. Potentially inappropriate medication in elderly hospitalized patients. Drugs Aging. 2009;26(Suppl 1):31-39. https://doi.org/10.2165/11534640-000000000-00000

Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57-65. https://doi.org/10.1517/14740338.2013.827660

Shah KN, Joshi HM, Christian RP, Patel KP, Malhotra SD. Prevalence of potentially inappropriate medications and prescription cost analysis among older cardiac patients in an outpatient department of a tertiary care hospital in India. J Basic Clin Pharm. 2016;7(4):110-115. https://doi.org/10.4103/0976-0105.189434

Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31-32):543-551. https://doi.org/10.3238/arztebl.2010.0543

Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254-1268. https://doi.org/10.1111/bcp.12732

Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-834. https://doi.org/10.1001/jamainternmed.2015.0324

Sweta K, Bhat D, Saraswathy GR, Maheswari E. The Views of Indian Practitioners on Deprescribing. J Gen Intern Med. 2019;34(6):828-830. https://doi.org/10.1007/s11606-018-4808-9

Scott IA, Gray LC, Martin JH, Mitchell CA. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125(6):529-537. https://doi.org/10.1016/j.amjmed.2011.09.021

Griebling TL. Re: Factors Influencing Deprescribing Habits among Geriatricians. J Urol. 2016;195(3):669. https://doi.org/10.1016/j.juro.2015.12.059

Sivagnanam G. Deprescription: The prescription metabolism. J Pharmacol Pharmacother. 2016;7(3):133-137. https://doi.org/10.4103/0976-500x.189680

Paque K, Vander Stichele R, Elseviers M, et al. Barriers and enablers to deprescribing in people with a life-limiting disease: A systematic review. Palliat Med. 2019;33(1):37-48. https://doi.org/10.1177/0269216318801124

Chou J, Tong M, Brandt NJ. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications. J Gerontol Nurs. 2019;45(1):9-15. https://doi.org/10.3928/00989134-20190102-01

Kuhn-Thiel AM, Weiß C, Wehling M; FORTA authors/expert panel members. Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging. 2014;31(2):131-140. https://doi.org/10.1007/s40266-013-0146-0

Barry PJ, O'Keefe N, O'Connor KA, O'Mahony D. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther. 2006;31(6):617-626. https://doi.org/10.1111/j.1365-2710.2006.00783.x

Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe. J Am Geriatr Soc. 2013;61(9):1508-1514. https://doi.org/10.1111/jgs.12418

Blanco JR, Morillo R, Abril V, et al. Deprescribing of non-antiretroviral therapy in HIV-infected patients. Eur J Clin Pharmacol. 2020;76(3):305-318. https://doi.org/10.1007/s00228-019-02785-z

Reeve E, Bell JS, Hilmer SN. Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review. Curr Clin Pharmacol. 2015;10(3):168-177. https://doi.org/10.2174/157488471003150820150330

Reeve E, Low LF, Shakib S, Hilmer SN. Development and Validation of the Revised Patients' Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers. Drugs Aging. 2016;33(12):913-928. https://doi.org/10.1007/s40266-016-0410-1

Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170(18):1648-1654. https://doi.org/10.1001/archinternmed.2010.355

Hortal Carmona J, Aguilar Cruz I, Parrilla Ruiz F. Un modelo de deprescripción prudente [A prudent deprescription model]. Med Clin (Barc). 2015;144(8):362-369. https://doi.org/10.1016/j.medcli.2014.02.026

Trenaman S, Willison M, Robinson B, Andrew M. A collaborative intervention for deprescribing: The role of stakeholder and patient engagement. Res Social Adm Pharm. 2020;16(4):595-598. https://doi.org/10.1016/j.sapharm.2019.07.004

Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673-1680. https://doi.org/10.1001/jamainternmed.2018.4720

Shrestha S, Giri R, Sapkota HP, et al. Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe. Ther Adv Drug Saf. 2021;12:20420986211019309. https://doi.org/10.1177/20420986211019309

Portman D. De-prescription. Fam Syst Health. 2017;35(3):389-390. https://doi.org/10.1037/fsh0000292

Turner JP, Edwards S, Stanners M, Shakib S, Bell JS. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open. 2016;6(3):e009781. https://doi.org/10.1136/bmjopen-2015-009781

Mishori R. What Needs to Change to Make Deprescribing Doable. Fam Pract Manag. 2018;25(3):5-6.

Shrestha S, Poudel A, Steadman K, Nissen L. Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review. Br J Clin Pharmacol. 2020;86(10):1931-1945. https://doi.org/10.1111/bcp.14113

Kua KP, Saw PS, Lee SWH. Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study. Int J Clin Pharm. 2019;41(3):793-803. https://doi.org/10.1007/s11096-019-00829-z

Williams ME, Pulliam CC, Hunter R, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52(1):93-98. https://doi.org/10.1111/j.1532-5415.2004.52016.x

Espeland MA, Whelton PK, Kostis JB, et al. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly. Arch Fam Med. 1999;8(3):228-236. https://doi.org/10.1001/archfami.8.3.228

Turner JP, Martin P, Zhang YZ, Tannenbaum C. Patients beliefs and attitudes towards deprescribing: Can deprescribing success be predicted?. Res Social Adm Pharm. 2020;16(4):599-604. https://doi.org/10.1016/j.sapharm.2019.07.007

Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. The benefits and harms of deprescribing. Med J Aust. 2014;201(7):386-389. https://doi.org/10.5694/mja13.00200

Martinez AI, Spencer J, Moloney M, Badour C, Reeve E, Moga DC. Attitudes toward deprescribing in a middle-aged health disparities population. Res Social Adm Pharm. 2020;16(10):1502-1507. https://doi.org/10.1016/j.sapharm.2020.02.014

Dharmarajan TS, Choi H, Hossain N, et al. Deprescribing as a Clinical Improvement Focus. J Am Med Dir Assoc. 2020;21(3):355-360. https://doi.org/10.1016/j.jamda.2019.08.031

Khairnar M, Naveen Kumar P, Kusumakar A. Updated BG prasad socioeconomic status classification for the year 2021. J Indian Assoc Public Health Dent. 2021;19:155. https://doi.org/10.4103/jiaphd.jiaphd_52_21